These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11563820)

  • 1. Human umbilical cord blood cells ameliorate Huntington's disease in transgenic mice.
    Ende N; Chen R
    J Med; 2001; 32(3-4):231-40. PubMed ID: 11563820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human umbilical cord blood cells ameliorate Alzheimer's disease in transgenic mice.
    Ende N; Chen R; Ende-Harris D
    J Med; 2001; 32(3-4):241-7. PubMed ID: 11563821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease mice and human umbilical cord blood.
    Ende N; Chen R
    J Med; 2002; 33(1-4):173-80. PubMed ID: 12939116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential for the use of mononuclear cells from human umbilical cord blood in the treatment of amyotrophic lateral sclerosis in SOD1 mice.
    Chen R; Ende N
    J Med; 2000; 31(1-2):21-30. PubMed ID: 10998753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human umbilical cord blood effect on sod mice (amyotrophic lateral sclerosis).
    Ende N; Weinstein F; Chen R; Ende M
    Life Sci; 2000 May; 67(1):53-9. PubMed ID: 10896029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Huntington's disease: the mystery unfolds?
    Petersén A; Brundin P
    Int Rev Neurobiol; 2002; 53():315-39. PubMed ID: 12512345
    [No Abstract]   [Full Text] [Related]  

  • 7. [Huntington's disease model mouse and neuronal cell death].
    Ishiguro H; Sawada H; Nishii K; Yamada K; Nagatsu T
    No To Shinkei; 2001 Sep; 53(9):829-37. PubMed ID: 11596477
    [No Abstract]   [Full Text] [Related]  

  • 8. Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model.
    Nguyen T; Hamby A; Massa SM
    Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11840-5. PubMed ID: 16087879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress towards a vaccine for Huntington's disease.
    Luthi-Carter R
    Mol Ther; 2003 May; 7(5 Pt 1):569-70. PubMed ID: 12718897
    [No Abstract]   [Full Text] [Related]  

  • 10. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.
    Reddy PH; Charles V; Williams M; Miller G; Whetsell WO; Tagle DA
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1035-45. PubMed ID: 10434303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Huntington's disease. Expanding horizons for treatment.
    McMurray CT
    Lancet; 2001 Dec; 358 Suppl():S37. PubMed ID: 11784586
    [No Abstract]   [Full Text] [Related]  

  • 12. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease.
    Yamamoto A; Lucas JJ; Hen R
    Cell; 2000 Mar; 101(1):57-66. PubMed ID: 10778856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyglutamine expansion and Huntington's disease.
    Bates GP; Mangiarini L; Wanker EE; Davies SW
    Biochem Soc Trans; 1998 Aug; 26(3):471-5. PubMed ID: 9765898
    [No Abstract]   [Full Text] [Related]  

  • 14. Huntington's disease. In reverse gear.
    Bates G
    Nature; 2000 Apr; 404(6781):944-5. PubMed ID: 10801109
    [No Abstract]   [Full Text] [Related]  

  • 15. Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.
    Valencia A; Reeves PB; Sapp E; Li X; Alexander J; Kegel KB; Chase K; Aronin N; DiFiglia M
    J Neurosci Res; 2010 Jan; 88(1):179-90. PubMed ID: 19642201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Huntington chorea in Drosophila and mice: toward new therapeutic steps].
    Liévens JC; Birman S
    Med Sci (Paris); 2003 May; 19(5):593-9. PubMed ID: 12836393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal models of Huntington's disease: implications in uncovering pathogenic mechanisms and developing therapies.
    Wang LH; Qin ZH
    Acta Pharmacol Sin; 2006 Oct; 27(10):1287-302. PubMed ID: 17007735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length.
    Hansson O; Castilho RF; Korhonen L; Lindholm D; Bates GP; Brundin P
    J Neurochem; 2001 Aug; 78(4):694-703. PubMed ID: 11520890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurobiology of Huntington's disease.
    Sharp AH; Ross CA
    Neurobiol Dis; 1996 Feb; 3(1):3-15. PubMed ID: 9173909
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinico-pathological rescue of a model mouse of Huntington's disease by siRNA.
    Wang YL; Liu W; Wada E; Murata M; Wada K; Kanazawa I
    Neurosci Res; 2005 Nov; 53(3):241-9. PubMed ID: 16095740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.